Literature DB >> 17925925

Non-functioning tumours of the pancreas in MEN1 patients.

Frederic Triponez, Guillaume Cadiot.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17925925

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


× No keyword cloud information.
  6 in total

Review 1.  Contemporary management of nonfunctioning pancreatic neuroendocrine tumors.

Authors:  Rebecca M Minter; Diane M Simeone
Journal:  J Gastrointest Surg       Date:  2011-10-19       Impact factor: 3.452

Review 2.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

3.  Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study.

Authors:  Kwadwo Antwi; Melpomeni Fani; Tobias Heye; Guillaume Nicolas; Christof Rottenburger; Felix Kaul; Elmar Merkle; Christoph J Zech; Daniel Boll; Deborah R Vogt; Beat Gloor; Emanuel Christ; Damian Wild
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-28       Impact factor: 9.236

Review 4.  Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.

Authors:  David C Metz; Robert T Jensen
Journal:  Gastroenterology       Date:  2008-08-12       Impact factor: 22.682

5.  Gastroenteropancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1.

Authors:  Francesco Tonelli; Francesco Giudici; Francesca Giusti; Maria Luisa Brandi
Journal:  Cancers (Basel)       Date:  2012-05-07       Impact factor: 6.639

Review 6.  Surgical management of pancreatic neuroendocrine neoplasms.

Authors:  Stefano Partelli; Angela Maurizi; Domenico Tamburrino; Stefano Crippa; Silvia Pandolfi; Massimo Falconi
Journal:  Ann Saudi Med       Date:  2014 Jan-Feb       Impact factor: 1.526

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.